Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases

Asahi Tomitaka, Ajeet Kaushik, Bhavesh D. Kevadiya, Insiya Mukadam, Howard Eliot Gendelman, Kamel Khalili, Gang Liu, Madhavan Nair

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Advanced central nervous system (CNS) therapies exhibited high efficacy but complete treatment of CNS diseases remains challenging owing to limited delivery of therapeutic agents to the brain. Multifunctional magnetic nanoparticles are investigated not only for site-specific drug delivery but also for theranostic applications aiming for an effective CNS therapy. Recently, surface engineering of magnetic nanoparticles was recognized as a crucial area of research to achieve precise therapy and imaging at molecular and cellular levels. This review reports state-of-the-art advancement in the development of surface-engineered magnetic nanoparticles targeting CNS diagnostics and therapies. The challenges and future prospects of magnetic theranostics are also discussed by considering the translation from bench to bedside. Successful translation of magnetic theranostics to the clinical setting will enable precise and efficient diagnostics and therapy to manage CNS diseases.

Original languageEnglish (US)
Pages (from-to)873-882
Number of pages10
JournalDrug Discovery Today
Volume24
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Central Nervous System Diseases
Nanoparticles
Central Nervous System
Therapeutics
Molecular Imaging
Brain
Research
Pharmaceutical Preparations
Theranostic Nanomedicine

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Tomitaka, A., Kaushik, A., Kevadiya, B. D., Mukadam, I., Gendelman, H. E., Khalili, K., ... Nair, M. (2019). Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases. Drug Discovery Today, 24(3), 873-882. https://doi.org/10.1016/j.drudis.2019.01.006

Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases. / Tomitaka, Asahi; Kaushik, Ajeet; Kevadiya, Bhavesh D.; Mukadam, Insiya; Gendelman, Howard Eliot; Khalili, Kamel; Liu, Gang; Nair, Madhavan.

In: Drug Discovery Today, Vol. 24, No. 3, 01.03.2019, p. 873-882.

Research output: Contribution to journalReview article

Tomitaka, A, Kaushik, A, Kevadiya, BD, Mukadam, I, Gendelman, HE, Khalili, K, Liu, G & Nair, M 2019, 'Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases', Drug Discovery Today, vol. 24, no. 3, pp. 873-882. https://doi.org/10.1016/j.drudis.2019.01.006
Tomitaka, Asahi ; Kaushik, Ajeet ; Kevadiya, Bhavesh D. ; Mukadam, Insiya ; Gendelman, Howard Eliot ; Khalili, Kamel ; Liu, Gang ; Nair, Madhavan. / Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases. In: Drug Discovery Today. 2019 ; Vol. 24, No. 3. pp. 873-882.
@article{123f146734a94aafbe30f7742fcc2981,
title = "Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases",
abstract = "Advanced central nervous system (CNS) therapies exhibited high efficacy but complete treatment of CNS diseases remains challenging owing to limited delivery of therapeutic agents to the brain. Multifunctional magnetic nanoparticles are investigated not only for site-specific drug delivery but also for theranostic applications aiming for an effective CNS therapy. Recently, surface engineering of magnetic nanoparticles was recognized as a crucial area of research to achieve precise therapy and imaging at molecular and cellular levels. This review reports state-of-the-art advancement in the development of surface-engineered magnetic nanoparticles targeting CNS diagnostics and therapies. The challenges and future prospects of magnetic theranostics are also discussed by considering the translation from bench to bedside. Successful translation of magnetic theranostics to the clinical setting will enable precise and efficient diagnostics and therapy to manage CNS diseases.",
author = "Asahi Tomitaka and Ajeet Kaushik and Kevadiya, {Bhavesh D.} and Insiya Mukadam and Gendelman, {Howard Eliot} and Kamel Khalili and Gang Liu and Madhavan Nair",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.drudis.2019.01.006",
language = "English (US)",
volume = "24",
pages = "873--882",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases

AU - Tomitaka, Asahi

AU - Kaushik, Ajeet

AU - Kevadiya, Bhavesh D.

AU - Mukadam, Insiya

AU - Gendelman, Howard Eliot

AU - Khalili, Kamel

AU - Liu, Gang

AU - Nair, Madhavan

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Advanced central nervous system (CNS) therapies exhibited high efficacy but complete treatment of CNS diseases remains challenging owing to limited delivery of therapeutic agents to the brain. Multifunctional magnetic nanoparticles are investigated not only for site-specific drug delivery but also for theranostic applications aiming for an effective CNS therapy. Recently, surface engineering of magnetic nanoparticles was recognized as a crucial area of research to achieve precise therapy and imaging at molecular and cellular levels. This review reports state-of-the-art advancement in the development of surface-engineered magnetic nanoparticles targeting CNS diagnostics and therapies. The challenges and future prospects of magnetic theranostics are also discussed by considering the translation from bench to bedside. Successful translation of magnetic theranostics to the clinical setting will enable precise and efficient diagnostics and therapy to manage CNS diseases.

AB - Advanced central nervous system (CNS) therapies exhibited high efficacy but complete treatment of CNS diseases remains challenging owing to limited delivery of therapeutic agents to the brain. Multifunctional magnetic nanoparticles are investigated not only for site-specific drug delivery but also for theranostic applications aiming for an effective CNS therapy. Recently, surface engineering of magnetic nanoparticles was recognized as a crucial area of research to achieve precise therapy and imaging at molecular and cellular levels. This review reports state-of-the-art advancement in the development of surface-engineered magnetic nanoparticles targeting CNS diagnostics and therapies. The challenges and future prospects of magnetic theranostics are also discussed by considering the translation from bench to bedside. Successful translation of magnetic theranostics to the clinical setting will enable precise and efficient diagnostics and therapy to manage CNS diseases.

UR - http://www.scopus.com/inward/record.url?scp=85060737896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060737896&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2019.01.006

DO - 10.1016/j.drudis.2019.01.006

M3 - Review article

VL - 24

SP - 873

EP - 882

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 3

ER -